Blau Farmacêutica
Pharmaceutical ManufacturingSão Paulo, Brazil1001-5000 Employees
Blau Farmacêutica is a Brazilian multinational in pharmaceutical manufacturing that holds a leading position in the institutional segment and is described as a pioneer in biotechnology in the country. It is publicly traded on the Brazilian stock exchange under the ticker BLAU3. The company focuses on delivering innovative medicines of high therapeutic complexity, with an emphasis on efficacy, safety, and quality to support therapeutic decisions made by medical teams and health professionals. Its portfolio includes proprietary medicines spanning immunology, hematology, oncology, nephrology, infectious diseases, and anesthesiology. Blau operates five manufacturing facilities in Brazil and an active pharmaceutical ingredient plant, all equipped with advanced technology and integrated monitoring and control systems, aligned with international good manufacturing practices. The company maintains a Latin American footprint—Argentina, Chile, Colombia, Ecuador, Mexico, Peru, and Uruguay—and conducts activity in the United States through Hemarus, its plasma collection centers; it is based in São Paulo and is a sizeable employer.
1-888-653-2347 
support@leadiq.com 
